Google’s stealthy biotech upstart Calico announced today that it has inked its first licensing pact with UT Southwestern in Dallas to gain development rights to protective P7C3 compounds that appear to guard against Parkinson’s disease, amyotrophic lateral sclerosis and depression and set up labs in the Dallas area to support its development program.

…read more

Source: Google’s stealthy Calico inks an R&D deal for new compounds aimed at neurodegeneration


0 No comments